Cerebrovascular diseases

This group’s main lines are:

Stroke and cerebrovascular diseases.

  • Biomolecular markers of ischaemia and new therapeutic targets.
  • Interventional neuroradiology and emerging therapies.
  • Health care for the population/stroke code system.
  • Telemedicine.

Epilepsy

  • Drug-resistant epilepsy.

Movement disorders

  • Parkinson’s disease in young patients.
  • Parkinson’s disease. Monitoring and control aided by new technologies.

Cognitive impairment and dementia.

  • Mild cognitive impairment and dementia in very old patients.
  • Cognitive impairment and dementia in Down syndrome.

Multiple sclerosis.

  • Result markers and new therapies.

Headaches

  • Botulinum toxin in chronic migraine.
  • Occipital nerve block for the treatment of headaches.

This group’s future research will focus on:

  • Innovation projects in migraine and stroke: Integrated device for multivariable and outpatient monitoring of clinical and environmental parameters (FIS, TEC and Horizon H2020).
  • Translational study: Role of toll-like receptors in Myasthenia gravis.
  • New biomarkers in drug-refractory epilepsy and multiple sclerosis.
  • Privately funded clinical trials. Phase III studies. Multiple sclerosis, cerebral infarction, Parkinson’s disease, Alzheimer’s disease and epilepsy.
  • EEG monitoring in stroke patients in acute phase using new devices for capturing parameters by telemetry in the stroke unit.

Team members

area2_Linea6_G35_Dr-Vivancos

Group leader:

José Aurelio Vivancos Mora

Hospital Universitario La Princesa

   Other team members. Hospital Universitario La Princesa:

  • Teresa Carreras Rodríguez
  • María de Toledo Heras
  • Ana Beatriz Gago Veiga
  • Fabiola García Vaz
  • Beatriz González García
  • Lydia López Manzanares
  • Virginia Meca Lallana
  • Noemí Mora Pérez
  • Florentino Nombela Merchán
  • Gemma Reig Rosello
  • Mónica Sobrado Sanz
  • Santiago Trillo Senín
  • Aranzazu Vázquez Doce
  • Álvaro Ximenez-Carrillo Rico
  • Gustavo Enrique Zapata Wainberg

Vivancos Mora, José Aurelio. I2M2: Imagen molecular multimodal de la inflamacion. S2010/BMD-2349. CAM. 2012-2015.

Vivancos Mora, José Aurelio. REgenerative Stem cell therapy for STroke in Europe –Therapeutic efficacy of allogenic adipose tissue derived mesenchymal stem cells for enhancing functional outcome in stroke patients. Comisión Europea. 2015-2020.

Vivancos Mora, José Aurelio. Monitorización ambulatoria no invasiva de variables biométricas y biofísicas y como método para la predicción de una crisis de migraña. PI15/01976. ISCIII. 2016-2018.

Vivancos Mora, José Aurelio. MULTITARGET&VIEW: Imagen multimodal de la respuesta terapéutica a estrategias multidiana en enfermedades neurológicas. B2017/BMD-3688. CAM 2017-2021.

Esta ayuda esta cofinanciada con los programas operativos del Fondo Social Europeo y del Fondo Europeo de Desarrollo Regional, 2014-2020, de la Comunidad de Madrid.

Vivancos Mora, José Aurelio. Detención de Fibrilación Auricular EScondida en Atención Primaria en población Categorizada por riesgo con Un sistema de Banda de Registro ECG de larga duración: Estudio DESCUBRE-FA. PI18/00361. ISCIII. 2019-2021.

Demostrar si el uso de textiles biomédicos (wearables), mejora la detección de fibrilación auricular frente a los métodos diagnósticos tradicionales.

This grant is funded by the 2017-2020 Spanish Science, Technology and Innovation Research Plan and the ISCIII – Subdirectorate General for Evaluation and Promotion of Research – and co-financed by the European Regional Development Fund, Operational Programme Smart Growth 2014-2020 according to Regulation (EU) no. 1303/2013.

Vivancos J, Gilo F, Frutos R, Maestre J, García-Pastor A, Quintana F, Roda JM, Ximénez-Carrillo A, Díez Tejedor E, Fuentes B, Alonso de Leciñana M, Alvarez-Sabin J, Arenillas J, Calleja S, Casado I, Castellanos M, Castillo J, Dávalos A, Díaz-Otero F, Egido JA, Fernández JC, Freijo M, Gállego J, Gil-Núñez A, Irimia P, Lago A, Masjuan J, Martí-Fábregas J, Martínez-Sánchez P, Martínez-Vila E, Molina C, Morales A, Nombela F, Purroy F, Ribó M, Rodríguez-Yañez M, Roquer J, Rubio F, Segura T, Serena J, Simal P, Tejada J. Clinical management guidelines for subarachnoid haemorrhage. Diagnosis and treatment. Neurologia 2014. 29: 353-370. FI: 1.381(Q4). PMID: 23044408. DOI: 10.1016/j.nrl.2012.07.009.

Nombela F, Blanco M, Pérez de la Ossa N, Caniego JL, Sobrino T, Escudero D, Campos F, Moro MÁ, Lizasoaín I, Dávalos A, Castillo J, Vivancos J. Neuronal Excitotoxicity after Carotid Angioplasty and Stent Placement Procedures. Radiology 2013. 268: 515-520. FI: 6.214(Q1). PMID: 23525205. DOI: 10.1148/radiol.13112104.

Zapata-Wainberg G, Vivancos J. Bilateral Earlobe Creases. N Engl J Med 2013. 368: 32-0. FI: 54.420(Q1). PMID: 23758258. DOI: 10.1056/NEJMicm1213006.

Godino Mdel C, Romera VG, Sánchez-Tomero JA, Pacheco J, Canals S, Lerma J, Vivancos J, Moro MA, Torres M, Lizasoain I, Sánchez-Prieto J. Amelioration of ischaemic brain damage by peritoneal dialysis. J. Clin. Invest. 2013. 123: 4359-4363. FI: 13.765(Q1). PMID: 23999426. DOI: 10.1172/JCI67284.

Rodriguez-Yanez, Manuel, Sobrino, Tomas, Arias, Susana, Vazquez-Herrero, Fernando, Brea, David, Blanco, Miguel, Leira, Rogelio, Castellanos, Mar, Serena, Joaquin, Vivancos, Jose, Davalos, Antonio, Castillo, Jose. Early Biomarkers of Clinical-Diffusion Mismatch in Acute Ischemic Stroke. Stroke 2011. 42: 2813-212. FI: 5.729(Q1). PMID: 21836082. DOI: 10.1161/STROKEAHA.111.614503.